Stromal-Modulated Epithelial-to-Mesenchymal Transition in Cancer Cells
Biomolecules · 01.11.2023 · 13 (11) · 1604
DOI: 10.3390/biom13111604 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 01.11.2023. Verfasst von Huda I Atiya und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology/Oncology, Department of Medicine, Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA 15261, USA. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gibson Family Fund.
Abstract (Originalsprache)
The ability of cancer cells to detach from the primary site and metastasize is the main cause of cancer- related death among all cancer types. Epithelial-to-mesenchymal transition (EMT) is the first event of the metastatic cascade, resulting in the loss of cell–cell adhesion and the acquisition of motile and stem-like phenotypes. A critical modulator of EMT in cancer cells is the stromal tumor microenvironment (TME), which can promote the acquisition of a mesenchymal phenotype through direct interaction with cancer cells or changes to the broader microenvironment. In this review, we will explore the role of stromal cells in modulating cancer cell EMT, with particular emphasis on the function of mesenchymal stromal/stem cells (MSCs) through the activation of EMT-inducing pathways, extra cellular matrix (ECM) remodeling, immune cell alteration, and metabolic rewiring.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Hematology/Oncology, Department of Medicine, Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA 15261, USA.
- Medical Scientist Training Program, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15261, USA.
- Department of Integrative Systems Biology, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15261, USA.
- Molecular Pharmacology Graduate Program, University of Pittsburgh, Pittsburgh, PA 15261, USA.
- Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Sciences, Magee Women's Research Institute, Pittsburgh, PA15213, USA.
ORCID-Profile: Grace Gorecki
Förderung
- Gibson Family Fund
Zitieren
APA
Atiya, H. I., Gorecki, G., Garcia, G. L., Frisbie, L. G., Baruwal, R., & Coffman, L. (2023). Stromal-Modulated Epithelial-to-Mesenchymal Transition in Cancer Cells. Biomolecules, 13(11), 1604. https://doi.org/10.3390/biom13111604
Vancouver
Atiya HI, Gorecki G, Garcia GL, Frisbie LG, Baruwal R, Coffman L. Stromal-Modulated Epithelial-to-Mesenchymal Transition in Cancer Cells. Biomolecules. 2023;13(11):1604. doi:10.3390/biom13111604
BibTeX
@article{Atiya2023,
author = {Atiya, Huda I and Gorecki, Grace and Garcia, Geyon L and Frisbie, Leonard G and Baruwal, Roja and Coffman, Lan},
title = {Stromal-Modulated Epithelial-to-Mesenchymal Transition in Cancer Cells},
journal = {Biomolecules},
year = {2023},
volume = {13},
number = {11},
pages = {1604},
doi = {10.3390/biom13111604}
}
EUVIMED